2010•Zhongguo huxi yu weizhong jianhu zazhiRequires access

Effects of Extracellular Signal Regulated Kinase Signaling Pathway on Cell Cycle of Airway Smooth Muscle Cells in Asthmatic Rats

Wan Ni

Open publisher page 1 citations

Abstract

Objective To investigate the effects of extracellular signal regulated kinase(ERK) signaling pathway on cell cycle of airway smooth muscle cells(ASMCs) in asthmatic rats.Methods Thirty Wistar rats were randomly assigned to a control group and an asthma group(15 rats in each group).Asthma model was established by ovalbumim sensitization and challenge.ASMC were isolated and cultured in vitro.The ASMCs from the asthmatic rats were treated with ERK activator epidermal growth factor (EGF) and inhibitor PD98059,respectively.The expressions of cyclin D1 and CDK2 in ASMCs were detected by immunocytochemical staining.The expressions of ERK1/2 and p-ERK1/2 protein were observed by western blotting for measurement of ERK activation rate.Results Compared with the control group[54.17±6.11,61.04±4.09,(49.91±3.26)%,respectively],the expressions of cyclin D1 protein and CDK2 protein,and the rate of ERK activation of ASMCs from the asthmatic rats significantly increased[76.15±4.88,92.30±7.95,(82.37±5.78)%,respectively] (P0.05).Furthermore,compared with those before treatment,the expression of cyclin D1 and CDK2,and the rate of ERK activation of ASMCs significantly decreased after treatment with PD98059 [58.78±4.60,69.15±5.83,(54.01±4.12)%,respectively](P0.05),and significantly increased after treatment with EGF[119.28±8.14,134.77±9.26,(91.57±5.32)%,respectively](P0.05).Conclusion ERK1/2 participates in proliferation regulation of ASMCs in asthma by enhancing the expressions of cyclin D1 and CDK2,which promotes quiescent cells into S phase.

About this research paper

What this paper is about

Objective To investigate the effects of extracellular signal regulated kinase(ERK) signaling pathway on cell cycle of airway smooth muscle cells(ASMCs) in asthmatic rats.Methods Thirty Wistar rats were randomly assigned to a control group and an asthma group(15 rats in each group).Asthma model was established by ovalbumim sensitization and challenge.ASMC were isolated and cultured in vitro.The ASMCs from the asthmatic rats were treated with ERK activator epidermal growth factor (EGF) and inhibitor PD98059,respectively.The expressions of cyclin D1 and CDK2 in ASMCs were detected by immunocytochemical staining.The expressions of ERK1/2 and p-ERK1/2 protein were observed by western blotting for measurement of ERK activation rate.Results Compared with the control group[54.17±6.11,61.04±4.09,(49.91±3.26)%,respectively],the expressions of cyclin D1 protein and CDK2 protein,and the rate of ERK activation of ASMCs from the asthmatic rats significantly increased[76.15±4.88,92.30±7.95,(82.37±5.78)%,respectively] (P0.05).Furthermore,compared with those before treatment,the expression of cyclin D1 and CDK2,and the rate of ERK activation of ASMCs significantly decreased after treatment with PD98059 [58.78±4.60,69.15±5.83,(54.01±4.12)%,respectively](P0.05),and significantly increased after treatment with EGF[119.28±8.14,134.77±9.26,(91.57±5.32)%,respectively](P0.05).Conclusion ERK1/2 participates in proliferation regulation of ASMCs in asthma by enhancing the expressions of cyclin D1 and CDK2,which promotes quiescent cells into S phase.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effects of extracellular signal regulated kinase(ERK) signaling pathway on cell cycle of airway smooth muscle cells(ASMCs) in asthmatic rats.Methods Thirty Wistar rats were randomly assigned to a control group and an asthma group(15 rats in each group).Asthma model was established by ovalbumim sensitization and challenge.ASMC were isolated and cultured in vitro.The ASMCs from the asthmatic rats were treated with ERK activator epidermal growth factor (EGF) and inhibitor PD98059,respectively.The expressions of cyclin D1 and CDK2 in ASMCs were detected by immunocytochemical staining.The expressions of ERK1/2 and p-ERK1/2 protein were observed by western blotting for measurement of ERK activation rate.Results Compared with the control group[54.17±6.11,61.04±4.09,(49.91±3.26)%,respectively],the expressions of cyclin D1 protein and CDK2 protein,and the rate of ERK activation of ASMCs from the asthmatic rats significantly increased[76.15±4.88,92.30±7.95,(82.37±5.78)%,respectively] (P0.05).Furthermore,compared with those before treatment,the expression of cyclin D1 and CDK2,and the rate of ERK activation of ASMCs significantly decreased after treatment with PD98059 [58.78±4.60,69.15±5.83,(54.01±4.12)%,respectively](P0.05),and significantly increased after treatment with EGF[119.28±8.14,134.77±9.26,(91.57±5.32)%,respectively](P0.05).Conclusion ERK1/2 participates in proliferation regulation of ASMCs in asthma by enhancing the expressions of cyclin D1 and CDK2,which promotes quiescent cells into S phase.

Key concepts: MAPK/ERK pathway, Kinase, Cyclin-dependent kinase 2, Medicine, Cyclin D1, Extracellular, Internal medicine, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Extracellular Signal Regulated Kinase Signaling Pathway on Cell Cycle of Airway Smooth Muscle Cells in Asthmatic Rats — Research Paper | ScholarLens